Skip to content
Open access

Histone H3K18 Lactylation Drives Immunosuppression by Upregulating CD38 in Myeloid-Derived Suppressor Cells in Lung Cancer.

Sep 2026 · Cancer immunology research · 0 citations
Medicine

TL;DR

The findings reveal the critical role of the lactate-CD38-NAD⁺ axis in regulating MDSC immunosuppressive function and establish histone lactylation as an epigenetic mechanism controlling CD38 expression.

Abstract

Histone lactylation is an epigenetic modification that connects lactate metabolism with protein function. Our study identified lactate enhances the protein lactylation level not only in Myeloid-derived suppressor cells (MDSCs) of tumor-bearing mice, but also in the tumor tissues of lung cancer patients. This modification led to upregulation of CD38 expression and enhanced the immunosuppressive function of MDSCs. Mechanistically, CD38 promoted immunosuppression by depleting NAD⁺, and treatment with CD38 inhibitor or siRNA-mediated knockdown of CD38 in MDSCs delayed tumor progression. H3K18la is enriched at CD38 promoter region, with p300, HDAC1-3, and BRD4 identified as key epigenetic regulators in this process. Our findings reveal the critical role of the lactate-CD38-NAD⁺ axis in regulating MDSC immunosuppressive function and establish histone lactylation as an epigenetic mechanism controlling CD38 expression.

Read PDF

Similar papers

Open access Oct 2026

Histone H4K5 lactylation-driven feedback loop modulates glycerol-linked immunosuppressive activity of tumor-associated T regulatory cells

Tumor metastasis is the leading cause of death for more than 90% of cancer patients, with colorectal cancer (CRC) mainly spreading to the liver. The colon and liver possess distinct nutritional microenvironments, yet how these differences shape the tumor immune landscape remains unclear. Using single-cell analysis of a...

Wang-Zheng Wang, Bai-Da Kong, Chang-Yuan Huang et al. · 0 citations
Open access Aug 2026

Lactate-Induced H3K18 Lactylation Attenuates T-Cell Activation and Upregulates PD-L1 in Esophageal Squamous Cell Carcinoma

Background: Immune checkpoint blockade targeting the Programmed Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) axis has demonstrated clinical activity in esophageal squamous cell carcinoma (ESCC). However, therapeutic responses remain limited in a substantial proportion of patients. Metabolic reprogramming and lactat...

Tao Liu, Guang-Sen He, Wen-Shou Zhong et al. · 0 citations
Open access Sep 2026

Dual Functions of B7-H3-MAPK Signaling Orchestrate Tumor Immunosuppression via Regulating the Plasticity of Myeloid-derived Suppressor Cells and Fibroblasts

B7-H3/CD276 is an emerging immunotherapy target in cancers. However, limited knowledge of B7-H3 signaling and its role in modulating the tumor microenvironment hinders the clinical application of B7-H3-targeting therapy. Here, we report that B7-H3 plays dual roles in regulating myeloid-derived suppressor cells (MDSCs)...

Wei Shi, Ping Xu, Qian-Lin Gu et al. · 0 citations
Open access Sep 2026

CAFs-mediated histone lactylation reprograms cholesterol metabolism in colorectal cancer to drive CD8+ T cell immunosuppression.

The central role of the CAF-CRC cell-CD8+ T cell regulatory axis is systematically elucidates: CAF-derived lactate modulates cholesterol metabolism in CRC cells via histone lactylation, thereby triggering mitochondrial dysfunction and driving the cellular senescence process.

Hua-Chi Li, Jun-Jie Hu, Lei Huang et al. · 0 citations
Open access Sep 2026

Lactate-associated H3K18la upregulates RNF166 to promote immune evasion in hepatocellular carcinoma by remodeling c-Jun ubiquitination

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, and PD-L1-mediated immune evasion is a major mechanism of tumor immune suppression and an important target of immune checkpoint blockade. Here, we identified RNF166 as an E3 ubiquitin ligase that promotes immune evasion in HCC. RNF166 expres...

B. Ren, Yi-Chen Yang, Kai-Wen Sheng et al. · 0 citations
Open access Oct 2026

Leucine-derived isovaleric acid remodels the tumor microenvironment by degrading EIF3I.

Metabolic reprogramming and immune evasion are hallmarks of cancer. Although leucine is well known for regulating protein synthesis, its role in immunometabolic interactions within the tumor microenvironment (TME) remains unclear. In this study, we found that leucine supplementation significantly inhibited tumor growth...

Jia-Hui Xu, Zi-Ming Wang, Chun-Li Wei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.